New cancer drug trial paused after early safety testing
Disease control
Terminated
This is an early-stage study to test the safety and find the right dose of a new drug called JSI-1187. It is being tested alone and in combination with an existing drug, dabrafenib, in adults with advanced solid tumors that have specific genetic changes. The trial is currently su…
Phase: PHASE1 • Sponsor: JS InnoPharm, LLC • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC